Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review

Saved in:
Bibliographic Details
Published in:Cancer Medicine
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871565536566968320
collection WordPress RSS
FRELIP Feed Integration
container_title Cancer Medicine
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:105911
institution FRELIP
journal_source_facet Cancer Medicine
last_indexed 2026-07-24T03:33:03.587Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review
title_alt Análisis farmacoeconómico de osimertinib en comparación con inhibidores de EGFR de generaciones anteriores en NSCLC con mutación de EGFR: Una revisión sistemática
Analyse pharmacoéconomique de l'osimertinib comparé aux inhibiteurs de l'EGFR de génération antérieure dans le CBNPC muté EGFR : une revue systématique
Análise Farmacoeconômica de Osimertinibe Comparado a Inibidores de EGFR de Gerações Anteriores em CPNPC com Mutação em EGFR: Uma Revisão Sistemática
title_auth Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review
title_es_txt Análisis farmacoeconómico de osimertinib en comparación con inhibidores de EGFR de generaciones anteriores en NSCLC con mutación de EGFR: Una revisión sistemática
title_fr_txt Analyse pharmacoéconomique de l'osimertinib comparé aux inhibiteurs de l'EGFR de génération antérieure dans le CBNPC muté EGFR : une revue systématique
title_full Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review
title_fullStr Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review
title_full_unstemmed Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review
title_pt_txt Análise Farmacoeconômica de Osimertinibe Comparado a Inibidores de EGFR de Gerações Anteriores em CPNPC com Mutação em EGFR: Uma Revisão Sistemática
title_short Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review
title_sort pharmacoeconomic analysis of osimertinib compared to earlier‐generation egfr inhibitors in egfr‐mutated nsclc: a systematic review
topic Oncology
General
Oncology
url https://onlinelibrary.wiley.com/doi/10.1002/cam4.72129?af=R